As of 2025-08-03, the Fair Value of Reviva Pharmaceuticals Holdings, Inc. (RVPH) is -1.96 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.44 USD, the upside of Reviva Pharmaceuticals Holdings, Inc. is -550.95%.
With the market price of 0.44 USD and our fair value calculation, Reviva Pharmaceuticals Holdings, Inc. (RVPH) is not a good investment. Investing in RVPH stocks now will result in a potential loss of 550.95%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -3.78 | -8.52 | -28.26 | -39.26 | -29.92 | -21.95 |
| YoY growth | -712.30% | -125.24% | -231.63% | -38.92% | 23.79% | -216.86% |
| Market Cap (mil) | 32.06 |
| P/E | |
| Forward P/E |
| EPS | -0.39 |
| Avg earnings growth rate | -216.86% |
| TTM earnings | -28.92 |